SUSAN MYERS: Open Payments
NPI 1992024491 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 11 payments from 8 companies in 2025. Trend: 2023 $452 · 2024 $179 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $39 |
| Organon LLC | 2 | $37 |
| ABBVIE INC. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $21 |
| Boston Scientific Corporation | 1 | $18 |
Products named: ABRYSVO, NEXPLANON, QULIPTA, Veozah, Mirena, GEMTESA, WATCHMAN FLX.
Industry payments across AR — which companies pay providers there.
